Surfeit 1 (SURF1) Peptide
SURF1
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN938801
Quick Overview for Surfeit 1 (SURF1) Peptide (ABIN938801)
Target
SURF1
(Surfeit 1 (SURF1))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- GLRAAGLGRA PASAAWRSVL RVSPRPGVAW RPSRCGSSAA EASATKAEDD
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SURF1 antibody,
Alternative Names: SURF1 control peptide, SURF1 antibody Blocking Peptide, Anti-SURF1 Blocking Peptide, surfeit 1 Blocking Peptide, SURF1, SURF-1, SURF 1, SURF-1 Blocking Peptide, SURF 1 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- SURF1 (Surfeit 1 (SURF1))
-
Background
- This gene encodes a protein localized to the inner mitochondrial membrane and thought to be involved in the biogenesis of the cytochrome c oxidase complex. The protein is a member of the SURF1 family, which includes the related yeast protein SHY1 and rickettsial protein RP733. The gene is located in the surfeit gene cluster, a group of very tightly linked genes that do not share sequence similarity, where it shares a bidirectional promoter with SURF2 on the opposite strand. Defects in this gene are a cause of Leigh syndrome, a severe neurological disorder that is commonly associated with systemic cytochrome c oxidase deficiency.
-
Molecular Weight
- 33 kDa
Target
-
You are here:
